@ckd_ce

Your source for joint-accredited serialized tweetorials in the CKD space! See all tweetorials--and still earn credit from AcademicCME--at https://xitter.cf/t.co/bUHAMqZzgE

ckd-ce.com
Joined July 2021
  • Tweets5.4K
  • Following40
  • Followers2.6K
2.5KMedia
11b) . . . the first Ph 3 results for #enlicitide, the leading candidate oral #PSCK9i, shown in early trials to ⬇️LDL by as much as 60%. PR just after ESC ➡️at AHA we'll see positive LLT results on that drug in the #CORALreef program. #LBCTs are scheduled to be presented.
1
1
49
1,170
@CKD_ce retweeted
@onc_ce
@onc_ceJun 17
Replying to @onc_ce @harrisoncn1
42) Congratulations! You are up to date from #EHA26 on advances in therapy for #anemia associated with #myelofibrosis, AND you also just earned 1 hour of 🆓CE/#CME credit! Claim your certificate now at oncologytweetorials-ce.com/m…. Many thanks to our 🏆expert faculty @harrisoncn1!

EHA2026: New Data on the Management of Anemia in Myelofibrosis | Oncology CE

2) Fortunately our intrepid correspondent & returning expert faculty Dr Claire Harrison @harrisoncn1, Prof of Haematology at the Guy’s & St. Thomas’ ...

oncologytweetorials-ce.com
6
20
1,175
@CKD_ce retweeted
@onc_ce
@onc_ceJun 17
22b) Duration of these responses, as well as the reduction in TB ≥ 50% with ≥ 4 units, was longer with #luspatercept compared with placebo
1
3
6
896
@CKD_ce retweeted
@onc_ce
@onc_ceJun 17
20) So now #EHA2026: On 13 June, Francesco Passamonti presented the updated results…. And here they are
1
5
6
903
@CKD_ce retweeted
@onc_ce
@onc_ceJun 17
8d) ... as a category 2A option for #MF-assoc#anaemia, esp for those with symptomatic #splenomegaly on a #JAKi, reflecting expert consensus & clinical need, not FDA approval. At #EHA2026: updated primary results from #INDEPENDENCE! But first, let’s see what you know already!
1
3
5
940
@CKD_ce retweeted
@onc_ce
@onc_ceJun 17
2) Fortunately our intrepid correspondent & returning expert faculty Dr Claire Harrison @harrisoncn1, Prof of Haematology at the Guy’s & St. Thomas’ NHS Foundation Trust @GSTTnhs in #London 🇬🇧was at #EHA2026 and has prepared this update on 🔑data.
1
7
1
20
1,614
@CKD_ce retweeted
@onc_ce
@onc_ceJun 17
1) #EHA2026 in #Stockholm 🇸🇪 is now in the books, but we’re still talking about very exciting presentations on the management of #anaemia in #myelofibrosis #MF that attracted great interest there.
1
6
21
1,411
1) Welcome to a new #accredited #tweetorial from @ckd_ce & @cardiomet_ce, addressing new & exciting data released in 2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.
1
7
12
1,884
more replies
20) While open questions remain regarding their comparative efficacy and safety against established #MRAs, #ASIs are actively being studied across the cardio-kidney-metabolic spectrum including in the prevention of #HF and in the treatment of HF and #CKD.
1
1
1,230
21) So, congratulations! 🥳🙌 You just earned 0.75hr 🆓 CE/#CME and you can claim it right now ⏱️at ckd-ce.com/hypertension5/ ! Thank you for joining us, please FOLLOW US for MORE #MedEd, and 🫡to our expert author @mvaduganathan!
1
1,066
Load more